Search

Your search keyword '"Maldonado, Reno"' showing total 12 results
Start Over Author "Maldonado, Reno"
12 results on '"Maldonado, Reno"'

6. MP56-06 ASSOCIATIONS BETWEEN SKELETAL MUSCLE GAUGE AND SURVIVAL FOLLOWING RADICAL CYSTECTOMY FOR BLADDER CANCER: A NOVEL ASSESSMENT OF MUSCLE MASS AND QUALITY

Author

Noonavath, Meghana, primary, Mun, Kevin, additional, Marquardt, J. Peter, additional, Fintelmann, Florian J., additional, O'Malley, Ryan, additional, Holt, Sarah K., additional, Dwyer, Erin, additional, Maldonado, Reno, additional, Diamantopoulos, Leonidas, additional, Makrakis, Dimitrios, additional, Laidlaw, Grace, additional, Schade, George R., additional, Lin, Dan W., additional, Wright, Jonathan L., additional, Gore, John L., additional, Nyame, Yaw, additional, Grivas, Petros, additional, Yu, Evan, additional, Montgomery, Bruce, additional, Hsieh, Andrew C., additional, Yezefski, Todd A., additional, Schweizer, Michael, additional, Cheng, Heather H., additional, and Psutka, Sarah P., additional

Published
2022
Full Text
View/download PDF

7. Changes in body composition during neoadjuvant platinum-based chemotherapy associations prior to radical cystectomy: Implications for chemotherapy-associated adverse events and oncologic outcomes.

Author

Maldonado, Reno, primary, Fintelmann, Florian J., additional, Marquardt, Jan Peter, additional, O'Malley, Ryan Blair, additional, Holt, Sarah K., additional, Ngo, Steven, additional, Diamantopoulos, Leonidas Nikolaos, additional, Laidlaw, Grace, additional, Schade, George R., additional, Lin, Daniel W., additional, Wright, Jonathan L., additional, Gore, John L., additional, Nyame, Yaw A., additional, Grivas, Petros, additional, Yu, Evan Y., additional, Montgomery, Robert B., additional, Hsieh, Andrew Caleb, additional, Yezefski, Todd, additional, Schweizer, Michael Thomas, additional, and Psutka, Sarah P., additional

Published
2022
Full Text
View/download PDF

8. Associations between baseline body composition and cancer-specific mortality following neoadjuvant chemotherapy and radical cystectomy for bladder cancer.

Author

Diamantopoulos, Leonidas Nikolaos, primary, Ngo, Steven, additional, Maldonado, Reno, additional, O'Malley, Ryan Blair, additional, Laidlaw, Grace, additional, Fintelmann, Florian J., additional, Holt, Sarah K, additional, Gore, John L., additional, Schade, George R., additional, Lin, Daniel W., additional, Grivas, Petros, additional, Montgomery, Robert B., additional, Hsieh, Andrew Caleb, additional, Cheng, Heather H., additional, Yezefski, Todd, additional, Schweizer, Michael Thomas, additional, Yu, Evan Y., additional, Wright, Jonathan L., additional, and Psutka, Sarah P., additional

Published
2020
Full Text
View/download PDF

9. Skeletal muscle index and adverse events during a bladder cancer treatment episode.

Author

Ngo, Steven, primary, Diamantopoulos, Leonidas Nikolaos, additional, Maldonado, Reno, additional, O'Malley, Ryan Blair, additional, Laidlaw, Grace, additional, Fintelmann, Florian J., additional, Holt, Sarah K, additional, Gore, John L., additional, Schade, George R., additional, Lin, Daniel W., additional, Grivas, Petros, additional, Montgomery, Robert B., additional, Hsieh, Andrew Caleb, additional, Cheng, Heather H., additional, Yezefski, Todd, additional, Schweizer, Michael Thomas, additional, Yu, Evan Y., additional, Wright, Jonathan L., additional, and Psutka, Sarah P., additional

Published
2020
Full Text
View/download PDF

11. Association between active commuting and incident cardiovascular disease, cancer, and mortality: prospective cohort study

Author

Celis-Morales, Carlos A, Lyall, Donald M, Welsh, Paul, Anderson, Jana, Steell, Lewis, Guo, Yibing, Maldonado, Reno, Mackay, Daniel F, Pell, Jill P, Sattar, Naveed, and Gill, Jason M R

Abstract

Objective To investigate the association between active commuting and incident cardiovascular disease (CVD), cancer, and all cause mortality.Design Prospective population based study. Setting UK Biobank.Participants 263 450 participants (106 674 (52%) women; mean age 52.6), recruited from 22 sites across the UK. The exposure variable was the mode of transport used (walking, cycling, mixed mode vnon-active (car or public transport)) to commute to and from work on a typical day.Main outcome measures Incident (fatal and non-fatal) CVD and cancer, and deaths from CVD, cancer, or any causes.Results 2430 participants died (496 were related to CVD and 1126 to cancer) over a median of 5.0 years (interquartile range 4.3-5.5) follow-up. There were 3748 cancer and 1110 CVD events. In maximally adjusted models, commuting by cycle and by mixed mode including cycling were associated with lower risk of all cause mortality (cycling hazard ratio 0.59, 95% confidence interval 0.42 to 0.83, P=0.002; mixed mode cycling 0.76, 0.58 to 1.00, P<0.05), cancer incidence (cycling 0.55, 0.44 to 0.69, P<0.001; mixed mode cycling 0.64, 0.45 to 0.91, P=0.01), and cancer mortality (cycling 0.60, 0.40 to 0.90, P=0.01; mixed mode cycling 0.68, 0.57 to 0.81, P<0.001). Commuting by cycling and walking were associated with a lower risk of CVD incidence (cycling 0.54, 0.33 to 0.88, P=0.01; walking 0.73, 0.54 to 0.99, P=0.04) and CVD mortality (cycling 0.48, 0.25 to 0.92, P=0.03; walking 0.64, 0.45 to 0.91, P=0.01). No statistically significant associations were observed for walking commuting and all cause mortality or cancer outcomes. Mixed mode commuting including walking was not noticeably associated with any of the measured outcomes.Conclusions Cycle commuting was associated with a lower risk of CVD, cancer, and all cause mortality. Walking commuting was associated with a lower risk of CVD independent of major measured confounding factors. Initiatives to encourage and support active commuting could reduce risk of death and the burden of important chronic conditions.

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results